Find Grants for Large Businesses
Find out if you qualify for verified grants for Large Businesses . Discover your eligibility and key funding details for Large Businesses from major foundations and government agencies.
HIV Prevention and Alcohol (R34 Clinical Trials Optional)
Deadline: May 7, 2026
Opportunity Number: PAS-25-161
Agency: National Institutes of Health
Open Date: November 25, 2024
Close Date: May 7, 2026
Status: Posted
CFDA Numbers: 93.273
NLM Research Grants in Biomedical Informatics and Data Science (R01 Clinical Trial Optional)
Deadline: March 5, 2026
Opportunity Number: PAR-25-238
Agency: National Institutes of Health
Open Date: November 25, 2024
Close Date: March 5, 2026
Status: Posted
CFDA Numbers: 93.879
Navigator Emergency Department Diversion Models for Non-Urgent Mental Health Concerns (R01 Clinical Trial Required)
Deadline: January 7, 2028
Opportunity Number: PAR-25-289
Agency: National Institutes of Health
Open Date: November 25, 2024
Close Date: January 7, 2028
Status: Posted
CFDA Numbers: 93.242
Navigator Emergency Department Diversion Models for Non-Urgent Mental Health Concerns (R34 Clinical Trial Required)
Deadline: January 7, 2028
Opportunity Number: PAR-25-288
Agency: National Institutes of Health
Open Date: November 25, 2024
Close Date: January 7, 2028
Status: Posted
CFDA Numbers: 93.242
New Approaches for Measuring Brain Changes Across Longer Timespans (R01 Clinical Trial Optional)
Deadline: May 7, 2027
Opportunity Number: PAR-25-279
Agency: National Institutes of Health
Open Date: November 25, 2024
Close Date: May 7, 2027
Status: Posted
CFDA Numbers: 93.396, 93.866, 93.865, 93.286
New Approaches for Measuring Brain Changes Across Longer Timespans (R21 Clinical Trial Optional)
Deadline: May 7, 2027
Opportunity Number: PAR-25-272
Agency: National Institutes of Health
Open Date: November 25, 2024
Close Date: May 7, 2027
Status: Posted
CFDA Numbers: 93.866, 93.396, 93.865
Prevention and Intervention Approaches for Fetal Alcohol Spectrum Disorders (R34 Clinical Trial Optional)
Deadline: January 7, 2027
Opportunity Number: PAR-25-159
Agency: National Institutes of Health
Open Date: November 25, 2024
Close Date: January 7, 2027
Status: Posted
CFDA Numbers: 93.273
Prevention and Intervention Approaches for Fetal Alcohol Spectrum Disorders (R61/R33 Clinical Trial Optional)
Deadline: November 17, 2026
Opportunity Number: PAR-25-158
Agency: National Institutes of Health
Open Date: November 25, 2024
Close Date: November 17, 2026
Status: Posted
CFDA Numbers: 93.273
The Role of Work in Health Disparities in the U.S. (R01 Clinical Trials Optional)
Deadline: January 7, 2028
Opportunity Number: PAR-25-292
Agency: National Institutes of Health
Open Date: November 25, 2024
Close Date: January 7, 2028
Status: Posted
CFDA Numbers: 93.866, 93.361, 93.393, 93.307, 93.399, 93.396, 93.279, 93.242
Catalyze Product Definition Medical Device prototype design/testing and disease target identification and assay development (R61/R33 - Clinical Trial Not Allowed)
Deadline: December 23, 2027
Opportunity Number: RFA-HL-26-019
Agency: National Institutes of Health
Open Date: November 22, 2024
Close Date: December 23, 2027
Status: Posted
CFDA Numbers: 93.837, 93.233, 93.839, 93.838
Catalyze: Enabling Technologies and Transformative Platforms for HLBS Research (R33 - Clinical Trials Not Allowed)
Deadline: December 23, 2027
Opportunity Number: RFA-HL-26-016
Agency: National Institutes of Health
Open Date: November 22, 2024
Close Date: December 23, 2027
Status: Posted
CFDA Numbers: 93.839, 93.233, 93.838, 93.837
Catalyze: Product Definition Medical Device Prototype Optimization (R33 - Clinical Trial Not Allowed)
Deadline: December 23, 2027
Opportunity Number: RFA-HL-26-020
Agency: National Institutes of Health
Open Date: November 22, 2024
Close Date: December 23, 2027
Status: Posted
CFDA Numbers: 93.839, 93.233, 93.837, 93.838
Catalyze: Product Definition for Small Molecules, Biologics and Combination Products - Target Identification and Validation, and Preliminary Product/Lead Series Identification (R61/R33 Clinical Trials Not Allowed)
Deadline: December 23, 2027
Opportunity Number: RFA-HL-26-017
Agency: National Institutes of Health
Open Date: November 22, 2024
Close Date: December 23, 2027
Status: Posted
CFDA Numbers: 93.839, 93.838, 93.233, 93.837
Catalyze: Product Definition for Small Molecules, Biologics, and Combination Products - Preliminary Product/Lead Series Identification and Combination Product Prototype (R33 - Clinical Trial Not Allowed)
Deadline: December 23, 2027
Opportunity Number: RFA-HL-26-018
Agency: National Institutes of Health
Open Date: November 22, 2024
Close Date: December 23, 2027
Status: Posted
CFDA Numbers: 93.839, 93.233, 93.838, 93.837
Mood and Psychosis Symptoms during the Menopause Transition (R01 Clinical Trial Optional)
Deadline: January 7, 2028
Opportunity Number: PAR-25-281
Agency: National Institutes of Health
Open Date: November 22, 2024
Close Date: January 7, 2028
Status: Posted
CFDA Numbers: 93.242, 93.313
Mood and Psychosis Symptoms during the Menopause Transition (R21 Clinical Trial Optional)
Deadline: January 7, 2028
Opportunity Number: PAR-25-282
Agency: National Institutes of Health
Open Date: November 22, 2024
Close Date: January 7, 2028
Status: Posted
CFDA Numbers: 93.242, 93.313
Occupational Safety and Health Training Project Grants (T03)
Deadline: October 26, 2028
Opportunity Number: RFA-OH-25-003
Agency: Centers for Disease Control and Prevention - ERA
Open Date: November 22, 2024
Close Date: October 26, 2028
Status: Posted
CFDA Numbers: 93.262
Seamless Early-Stage Clinical Drug Development (Phase 1 to 2a) for Novel therapeutic Agents for the Spectrum of Alzheimer's Disease (AD) and AD-related Dementias (ADRD) (UG3/UH3 Clinical Trial Required)
Deadline: November 19, 2026
Opportunity Number: PAR-25-226
Agency: National Institutes of Health
Open Date: November 22, 2024
Close Date: November 19, 2026
Status: Posted
CFDA Numbers: 93.242
Utilizing Invasive Recording and Stimulating Opportunities in Humans to Advance Neural Circuitry Understanding of Mental Health Disorders (R01 Clinical Trial Optional)
Deadline: January 7, 2028
Opportunity Number: PAR-25-290
Agency: National Institutes of Health
Open Date: November 22, 2024
Close Date: January 7, 2028
Status: Posted
CFDA Numbers: 93.242
Utilizing Invasive Recording and Stimulating Opportunities in Humans to Advance Neural Circuitry Understanding of Mental Health Disorders (R21 Clinical Trial Optional)
Deadline: January 7, 2028
Opportunity Number: PAR-25-291
Agency: National Institutes of Health
Open Date: November 22, 2024
Close Date: January 7, 2028
Status: Posted
CFDA Numbers: 93.242
BRAIN Initiative: Promoting Health for All Through BRAIN Technology Partnerships (R34 - Clinical Trials Not Allowed)
Deadline: June 17, 2026
Opportunity Number: RFA-NS-25-016
Agency: National Institutes of Health
Open Date: November 21, 2024
Close Date: June 17, 2026
Status: Posted
CFDA Numbers: 93.173, 93.866, 93.273, 93.853, 93.286, 93.279, 93.867, 93.242, 93.213, 93.865
Feasibility Clinical Trials of Mind and Body Interventions for NCCIH High Priority Research Topics (R34 Clinical Trial Required)
Deadline: November 17, 2026
Opportunity Number: PAR-25-274
Agency: National Institutes of Health
Open Date: November 21, 2024
Close Date: November 17, 2026
Status: Posted
CFDA Numbers: 93.213
Innovative Research in Cancer Nanotechnology (IRCN; R01 Clinical Trial Not Allowed)
Deadline: May 4, 2026
Opportunity Number: PAR-25-106
Agency: National Institutes of Health
Open Date: November 21, 2024
Close Date: May 4, 2026
Status: Posted
CFDA Numbers: 93.394, 93.395
Investigator Initiated Clinical Trials of Complementary and Integrative Interventions Delivered Remotely or via mHealth (R01 Clinical Trial Required)
Deadline: November 17, 2026
Opportunity Number: PAR-25-268
Agency: National Institutes of Health
Open Date: November 21, 2024
Close Date: November 17, 2026
Status: Posted
CFDA Numbers: 93.213
NCCIH Multi-Site Feasibility Clinical Trials of Mind and Body Interventions (R01 Clinical Trial Required)
Deadline: November 17, 2026
Opportunity Number: PAR-25-267
Agency: National Institutes of Health
Open Date: November 21, 2024
Close Date: November 17, 2026
Status: Posted
CFDA Numbers: 93.213
